Scottish value-based assessments "can fix end-of-life treatment problem
This article was originally published in Scrip
Executive Summary
As it stands, Scotland's health technology appraisal system is not fit for purpose, according to James Jopling, Breakthrough Breast Cancer's Scotland Director. However, new value-based assessments for drugs announced by the Scottish government last week, with a focus on end-of-life drugs, should do something to help the situation.